These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31389949)
1. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H Du B; Ding X; Wang H; Du Q; Xu T; Huang J; Zhou J; Cheng G J Mater Chem B; 2019 Aug; 7(31):4784-4793. PubMed ID: 31389949 [TBL] [Abstract][Full Text] [Related]
3. Albumin-MnO Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612 [TBL] [Abstract][Full Text] [Related]
4. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia. Song M; Liu T; Shi C; Zhang X; Chen X ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065 [TBL] [Abstract][Full Text] [Related]
5. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
6. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance. Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118 [TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier. Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653 [TBL] [Abstract][Full Text] [Related]
8. Hybrid manganese dioxide-bovine serum albumin nanostructure incorporated with doxorubicin and IR780 for enhanced breast cancer chemo-photothermal therapy. Yuan X; Yin Y; Zan W; Sun X; Yang Q Drug Deliv; 2019 Dec; 26(1):1254-1264. PubMed ID: 31760842 [TBL] [Abstract][Full Text] [Related]
9. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165 [TBL] [Abstract][Full Text] [Related]
10. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. Meng H; Mai WX; Zhang H; Xue M; Xia T; Lin S; Wang X; Zhao Y; Ji Z; Zink JI; Nel AE ACS Nano; 2013 Feb; 7(2):994-1005. PubMed ID: 23289892 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer. Cheng X; Li D; Sun M; He L; Zheng Y; Wang X; Tang R Colloids Surf B Biointerfaces; 2019 Sep; 181():185-197. PubMed ID: 31132609 [TBL] [Abstract][Full Text] [Related]
12. Overcoming chemotherapy resistance using pH-sensitive hollow MnO Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697 [TBL] [Abstract][Full Text] [Related]
14. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice. Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307 [TBL] [Abstract][Full Text] [Related]
15. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging. Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307 [TBL] [Abstract][Full Text] [Related]
16. A targeted and redox/pH-responsive chitosan oligosaccharide derivatives based nanohybrids for overcoming multidrug resistance of breast cancer cells. Jia L; Li Z; Zheng D; Li Z; Zhao Z Carbohydr Polym; 2021 Jan; 251():117008. PubMed ID: 33142574 [TBL] [Abstract][Full Text] [Related]
17. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer. Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378 [TBL] [Abstract][Full Text] [Related]
18. Targeting ETS1 with RNAi-based supramolecular nanoassemblies for multidrug-resistant breast cancer therapy. Wu M; Liu X; Jin W; Li Y; Li Y; Hu Q; Chu PK; Tang G; Ping Y J Control Release; 2017 May; 253():110-121. PubMed ID: 28302581 [TBL] [Abstract][Full Text] [Related]
19. PX478-loaded silk fibroin nanoparticles reverse multidrug resistance by inhibiting the hypoxia-inducible factor. Li Z; Cheng G; Zhang Q; Wu W; Zhang Y; Wu B; Liu Z; Tong X; Xiao B; Cheng L; Dai F Int J Biol Macromol; 2022 Dec; 222(Pt B):2309-2317. PubMed ID: 36228812 [TBL] [Abstract][Full Text] [Related]
20. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy. Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]